Uncapping NF-κB activity in pancreatic cancer.

نویسندگان

  • Sushma Gurumurthy
  • Nabeel Bardeesy
چکیده

Living cells must be capable of rapidly responding to intrinsic and environmental cues to ensure normal development and homeostasis. The NF-jB transcription factor mediates a series of such rapid-response programs, serving as a master regulator of gene transcription in cells subjected to inflammation, irradiation, or other stress states (Karin, 2009). While cells must be able to rapidly respond to NF-jB stimuli, it is similarly important to restrain sustained high NF-jB levels that can trigger chronic inflammation or cellular transformation. Results published by Lu et al (2011) in this issue of The EMBO Journal identify a novel mechanism that amplifies NF-jB activity; NF-jB upregulates mir301a, a microRNA (miRNA) that itself blocks the expression of an NF-jB inhibitor. The resulting positive feedback mechanism potentiates NF-jB target gene expression. While this pathway may be important for normal cellular stress responses, the authors show that its sustained induction in pancreatic cancer cells leads to constitutive NF-jB activity that drives tumour progression. NF-kB is largely regulated at the level of protein stability via a well-characterized kinase cascade that controls the targeting of this transcription factor to the proteasome (Karin, 2009). However, acute adaption to cellular stresses requires additional inputs that ensure rapid and potent NF-kB target gene regulation. Conversely, tight controls are needed to restrain the dangerous pro-inflammatory and transforming functions of elevated NF-kB signalling. Positive and negative feedback signalling networks are recurring themes in biology to achieve such regulation. Recent studies identified a major role of miRNAs as components of feedback signalling networks, as emphasized for NF-kB by Lu et al (2011). The authors sought to identify miRNAs that target the NF-kB pathway, with a particular focus on identifying candidates that activate NF-kB-mediated transcription. miRNAs (or miRs) are an evolutionarily conserved class of non-coding double-stranded RNA molecules that suppress expression of their target genes by imperfect binding to the 30UTR of target mRNA, leading to either blocked translation or degradation of the message (Garzon et al, 2010). Using an miRNA library screen based on a luciferase reporter, they identify miR301a as a striking activator of NF-kB. In silico approaches predict numerous putative targets of miR301a, including the known NF-kB-regulator Nkrf. Nkrf represses NF-kB transcriptional

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

miR-301a as an NF-κB activator in pancreatic cancer cells.

NF-κB is constitutively activated in most human pancreatic adenocarcinoma, which is a deadly malignancy with a 5-year survival rate of about 5%. In this work, we investigate whether microRNAs (miRNAs) contribute to NF-κB activation in pancreatic cancer. We demonstrate that miR-301a down-regulates NF-κB-repressing factor (Nkrf) and elevates NF-κB activation. As NF-κB promotes the transcription o...

متن کامل

استفاده از مهار کننده‌ فاکتور نسخه‌برداری NF - κB در جزایر پانکراس

Background: Pancreatic islet transplantation has been reported as an appropriate method for treatment of type I diabetes patients, however there are strong indications that cytokine and chemokines secreted from transplanted islets play an important role in islet graft rejection in different stage post-transplantation. The NF-kB signaling pathway is activated in response to the stress resulted f...

متن کامل

Pomalidomide promotes chemosensitization of pancreatic cancer by inhibition of NF-κB

Introduction: Nuclear factor κB (NF-κB) plays an important role in cancer progression and causes therapeutic resistance to chemotherapy. Pomalidomide, a third-generation immunomodulating drug derived from thalidomide, has been approved for uncontrolled multiple myeloma. We hypothesized that pomalidomide may inhibit the anticancer agent-induced NF-κB activity and enhance chemosensitization of co...

متن کامل

Downregulation of TRAF2 Mediates NIK-Induced Pancreatic Cancer Cell Proliferation and Tumorigenicity

BACKGROUND Increased levels of NF-κB are hallmarks of pancreatic ductal adenocarcinoma (PDAC) and both classical and alternative NF-κB activation pathways have been implicated. METHODOLOGY/PRINCIPAL FINDINGS Here we show that activation of the alternative pathway is a source for the high basal NF-κB activity in PDAC cell lines. Increased activity of the p52/RelB NF-κB complex is mediated thro...

متن کامل

Xanthohumol inhibits angiogenesis by suppressing nuclear factor‐κB activation in pancreatic cancer

Xantohumol, a prenylated chalcone from hops (Humulus lupulus L.), has been shown to inhibit proliferation in some cancers. However, little is known regarding the effects of xanthohumol in pancreatic cancer. We have previously reported that activation of the transcription factor nuclear factor-κB (NF-κB) plays a key role in angiogenesis in pancreatic cancer. In this study, we investigated whethe...

متن کامل

Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer.

PURPOSE Near equal rates of incidence and mortality emphasize the need for novel targeted approaches for better management of patients with pancreatic cancer. Inflammatory molecules NF-κB and STAT3 are overexpressed in pancreatic tumors. Inhibition of one protein allows cancer cells to survive using the other. The goal of this study is to determine whether targeting STAT3/NF-κB crosstalk with a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The EMBO journal

دوره 30 1  شماره 

صفحات  -

تاریخ انتشار 2011